{"id":"https://openalex.org/W4319657166","doi":"https://doi.org/10.1007/s41669-023-00391-5","title":"Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067","display_name":"Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067","alternate_titles":[],"publication_year":2023,"publication_date":"2023-02-09","ids":{"openalex":"https://openalex.org/W4319657166","doi":"https://doi.org/10.1007/s41669-023-00391-5","pmid":"https://pubmed.ncbi.nlm.nih.gov/36757569","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10169997"},"language":"en","primary_location":{"id":"doi:10.1007/s41669-023-00391-5","doi":"https://doi.org/10.1007/s41669-023-00391-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-023-00391-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-023-00391-5.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4262","issn":["2509-4262","2509-4254"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4319657166"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s41669-023-00391-5.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012929424","display_name":"Taihang Shao","orcid":"https://orcid.org/0000-0002-7730-0533","observed_orcids":["https://orcid.org/0000-0002-7730-0533"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Taihang Shao","raw_affiliation_strings":["Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079920224","display_name":"Mingye Zhao","orcid":"https://orcid.org/0000-0002-7709-9374","observed_orcids":["https://orcid.org/0000-0002-7709-9374"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Mingye Zhao","raw_affiliation_strings":["Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060693503","display_name":"Leyi Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Leyi Liang","raw_affiliation_strings":["Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069523303","display_name":"Lizheng Shi","orcid":"https://orcid.org/0000-0002-7827-6766","observed_orcids":["https://orcid.org/0000-0002-7827-6766"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Lizheng Shi","raw_affiliation_strings":["Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, 70118, USA. lshi1@tulane.edu","Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA,  70118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, 70118, USA. lshi1@tulane.edu","institution_ids":["https://openalex.org/I114832834"]},{"raw_affiliation_string":"Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA,  70118, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037377894","display_name":"Wenxi Tang","orcid":"https://orcid.org/0000-0002-3564-3626","observed_orcids":["https://orcid.org/0000-0002-3564-3626"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/resources","display_name":"Resources"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Wenxi Tang","raw_affiliation_strings":["Department of Public Affairs Management, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China. tokammy@cpu.edu.cn","School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China. tokammy@cpu.edu.cn","School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China"],"raw_orcid":"https://orcid.org/0000-0002-3564-3626","affiliations":[{"raw_affiliation_string":"Department of Public Affairs Management, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China. tokammy@cpu.edu.cn","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China. tokammy@cpu.edu.cn","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, China","institution_ids":["https://openalex.org/I161716053"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037377894","https://openalex.org/A5069523303"],"corresponding_institution_ids":["https://openalex.org/I114832834","https://openalex.org/I161716053"],"apc_list":{"value":3490,"currency":"USD","value_usd":3490},"apc_paid":{"value":3490,"currency":"USD","value_usd":3490},"fwci":3.0819,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.91797564,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"7","issue":"3","first_page":"383","last_page":"392"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/structural-uncertainty","display_name":"structural uncertainty","score":0.7419999837875366},{"id":"https://openalex.org/keywords/fractional-polynomials","display_name":"fractional polynomials","score":0.4749999940395355},{"id":"https://openalex.org/keywords/restricted-cubic-splines","display_name":"restricted cubic splines","score":0.9959999918937683},{"id":"https://openalex.org/keywords/royston-parmar-model","display_name":"Royston-Parmar model","score":0.9580000042915344},{"id":"https://openalex.org/keywords/generalized-additive-models","display_name":"generalized additive models","score":0.9860000014305115},{"id":"https://openalex.org/keywords/parametric-mixture-models","display_name":"parametric mixture models","score":0.9399999976158142},{"id":"https://openalex.org/keywords/mixture-cure-models","display_name":"mixture cure models","score":0.9850000143051147},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8809999823570251},{"id":"https://openalex.org/keywords/checkmate-067","display_name":"CheckMate 067","score":0.8270000219345093},{"id":"https://openalex.org/keywords/individual-patient-data","display_name":"individual patient data","score":0.5389999747276306},{"id":"https://openalex.org/keywords/data-maturity","display_name":"data maturity","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C132459708","wikidata":"https://www.wikidata.org/wiki/Q744069","display_name":"Extrapolation","level":2,"score":0.7546156048774719},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5631306767463684},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5513060092926025},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.51470547914505},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.47315821051597595},{"id":"https://openalex.org/C118084267","wikidata":"https://www.wikidata.org/wiki/Q26110","display_name":"Positive economics","level":1,"score":0.40191450715065},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4013901352882385},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3931881785392761},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3393346667289734},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21079328656196594},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.19671151041984558},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.16876918077468872}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s41669-023-00391-5","doi":"https://doi.org/10.1007/s41669-023-00391-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-023-00391-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-023-00391-5.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4262","issn":["2509-4262","2509-4254"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10169997","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10169997","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10169997/pdf/41669_2023_Article_391.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoecon Open","raw_type":"Text"},{"id":"pmid:36757569","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36757569","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - open","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharmo:v:7:y:2023:i:3:d:10.1007_s41669-023-00391-5","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s41669-023-00391-5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s41669-023-00391-5","doi":"https://doi.org/10.1007/s41669-023-00391-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-023-00391-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-023-00391-5.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4262","issn":["2509-4262","2509-4254"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3997949160","display_name":null,"funder_award_id":"72174207","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4319657166.pdf","grobid_xml":"https://content.openalex.org/works/W4319657166.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1974813242","https://openalex.org/W1982967337","https://openalex.org/W2068751422","https://openalex.org/W2133075384","https://openalex.org/W2144270949","https://openalex.org/W2332604647","https://openalex.org/W2516925855","https://openalex.org/W2527272317","https://openalex.org/W2589633700","https://openalex.org/W2751752943","https://openalex.org/W2753432434","https://openalex.org/W2904448678","https://openalex.org/W2917035693","https://openalex.org/W2941699169","https://openalex.org/W2946746631","https://openalex.org/W2970453966","https://openalex.org/W2976858976","https://openalex.org/W2977511836","https://openalex.org/W2996294603","https://openalex.org/W3113114096","https://openalex.org/W3117012558","https://openalex.org/W3118925877","https://openalex.org/W3132994416","https://openalex.org/W3133074867","https://openalex.org/W3176264952","https://openalex.org/W3185329659","https://openalex.org/W3217126890","https://openalex.org/W4200071451","https://openalex.org/W4206708921","https://openalex.org/W4220942562","https://openalex.org/W4221048747","https://openalex.org/W4291129604"],"related_works":["https://openalex.org/W4311332534","https://openalex.org/W4206708921","https://openalex.org/W4291129604","https://openalex.org/W2904448678","https://openalex.org/W3026470796","https://openalex.org/W7166186053","https://openalex.org/W4402683678","https://openalex.org/W2981597316","https://openalex.org/W2751752943","https://openalex.org/W3113041774"],"abstract_inverted_index":{"OBJECTIVES:":[0],"The":[1,31,147],"aim":[2],"of":[3,11,27,92,119,162,200,218,222,229],"this":[4,139,196],"study":[5,140],"was":[6,35,101,185],"to":[7,83,103,126,243],"compare":[8],"the":[9,24,85,105,163,198,216,245,253],"performance":[10,214],"different":[12,99,132],"extrapolation":[13,89,171],"modeling":[14],"techniques":[15,50,149,211],"and":[16,47,67,75,88,115,122,251],"analyze":[17],"their":[18],"impact":[19,130],"on":[20,144,256],"structural":[21,106,257],"uncertainties":[22],"in":[23,108,150,195,215],"economic":[25,109],"evaluations":[26],"cancer":[28,230],"immunotherapy.":[29],"METHODS:":[30],"individual":[32],"patient":[33],"data":[34,133,164,174,223],"reconstructed":[36],"through":[37],"published":[38],"Checkmate":[39,219],"067":[40],"Kaplan":[41],"Meier":[42],"curves.":[43],"Standard":[44],"parametric":[45,64,156],"models":[46,100,157,190],"six":[48],"flexible":[49,148],"were":[51,81,113],"tested,":[52],"including":[53],"fractional":[54],"polynomial,":[55],"restricted":[56],"cubic":[57],"splines,":[58],"Royston-Parmar":[59],"models,":[60,63,66],"generalized":[61],"additive":[62],"mixture":[65,68],"cure":[69],"models.":[70],"Mean":[71],"square":[72],"errors":[73],"(MSE)":[74],"bias":[76],"from":[77,98,176],"raw":[78],"survival":[79,237],"plots":[80],"used":[82,102],"test":[84],"model":[86,129,184,254],"fitness":[87],"performance.":[90],"Variability":[91],"estimated":[93],"incremental":[94],"cost-effectiveness":[95],"ratios":[96],"(ICERs)":[97],"inform":[104],"uncertainty":[107],"evaluations.":[110],"All":[111],"indicators":[112],"analyzed":[114],"compared":[116],"under":[117,131],"cut-offs":[118],"3":[120],"years":[121],"6.5":[123],"years,":[124],"respectively,":[125],"further":[127],"discuss":[128],"maturity.":[134,165,224],"R":[135],"Codes":[136],"for":[137],"reproducing":[138],"can":[141],"be":[142],"found":[143,187],"GitHub.":[145],"RESULTS:":[146],"general":[151],"performed":[152],"better":[153,213],"than":[154],"standard":[155],"with":[158,178,235],"smaller":[159],"MSE":[160,194],"irrespective":[161],"Survival":[166],"outcomes":[167],"projected":[168],"by":[169],"long-term":[170],"using":[172],"immature":[173,236],"differed":[175],"those":[177],"mature":[179],"data.":[180,238],"Although":[181],"a":[182],"best-performing":[183],"not":[186],"because":[188],"several":[189],"had":[191],"very":[192],"similar":[193],"case,":[197],"variability":[199],"modeled":[201],"ICERs":[202,228],"significantly":[203],"increased":[204],"when":[205,233],"prolonging":[206],"simulation":[207],"cycles.":[208],"CONCLUSIONS:":[209],"Flexible":[210],"show":[212],"case":[217],"067,":[220],"regardless":[221],"Model":[225],"choices":[226],"affect":[227],"immunotherapy,":[231],"especially":[232],"dealing":[234],"When":[239],"researchers":[240],"lack":[241],"evidence":[242],"identify":[244],"'right'":[246],"model,":[247],"we":[248],"recommend":[249],"identifying":[250],"revealing":[252],"impacts":[255],"uncertainty.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4319657166","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-02-10T00:00:00"}
